ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $777,384 | -27.9% | 30,426 | -19.0% | 0.00% | 0.0% |
| Q2 2023 | $1,077,966 | +2.0% | 37,586 | -14.7% | 0.00% | 0.0% |
| Q1 2023 | $1,056,358 | +56.2% | 44,070 | +10.5% | 0.00% | – |
| Q4 2022 | $676,382 | +330.8% | 39,881 | +276.9% | 0.00% | – |
| Q3 2022 | $157,000 | -25.2% | 10,581 | -21.1% | 0.00% | – |
| Q2 2022 | $210,000 | -67.4% | 13,413 | -44.0% | 0.00% | – |
| Q1 2022 | $645,000 | -26.5% | 23,948 | +1.1% | 0.00% | – |
| Q4 2021 | $877,000 | -11.0% | 23,687 | +14.9% | 0.00% | – |
| Q3 2021 | $985,000 | +39.9% | 20,616 | -0.9% | 0.00% | – |
| Q2 2021 | $704,000 | -12.3% | 20,801 | +7.1% | 0.00% | – |
| Q1 2021 | $803,000 | +1.1% | 19,429 | +6.1% | 0.00% | – |
| Q4 2020 | $794,000 | +81.3% | 18,312 | +79.6% | 0.00% | – |
| Q3 2020 | $438,000 | -98.2% | 10,197 | -98.0% | 0.00% | -100.0% |
| Q2 2020 | $24,383,000 | +54084.4% | 521,667 | +12308.8% | 0.02% | – |
| Q4 2019 | $45,000 | – | 4,204 | +8658.3% | 0.00% | – |
| Q3 2019 | $0 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |